Na Li, Ph.D., of Sino Biological and Yue Liu, Ph.D., of Ab Studio Inc. discuss how their companies are leveraging artificial intelligence, computer-aided antibody design, and traditional antibody development technologies to accelerate the development and manufacture of multispecific antibody candidates.
.svg)
